<DOC>
	<DOC>NCT00555074</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy and safety of sodium tungstate versus placebo in patients with obesity (grade I and II).</brief_summary>
	<brief_title>Sodium Tungstate in Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<criteria>BMI: 3039.9 Kg/m2 In case of male gender, 18 to 65 years old In case of female gender, diagnosis of menopause Body weight changes &lt; 3 kg in the last 3 months In case of arterial hypertension or dyslipemia, no changes in dose in the last 2 months Exclusion criteria: In case of female gender, absence of menopause Evidence of secondary causes of obesity Diabetes, type II Concomitant treatment with drugs affecting body weight Previous surgical intervention of obesity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>